DRMA
Dermata Therapeutics·NASDAQ
--
--(--)
--
--(--)
1.00 / 10
Underperform
Technical analysis rates DRMA at 1/10, indicating a poor chart. Both long lower and upper shadows dominate, signaling bearish pressure. No bullish patterns appear, and recent RSI shows overbought conditions, suggesting further downside risk.
Analysis Checks(0/2)
Long Lower Shadow
Score1/10
Win Rate39.53%
Hist. Signals86
Avg Return-2.42%
Score1/10
Win Rate39.53%
Hist. Signals86
Avg Return-2.42%
Long Upper Shadow
Score1/10
Win Rate40.74%
Hist. Signals81
Avg Return-3.33%
Score1/10
Win Rate40.74%
Hist. Signals81
Avg Return-3.33%
Long Lower Shadow
Score1/10
Win Rate39.53%
Hist. Signals86
Avg Return-2.42%
Score1/10
Win Rate39.53%
Hist. Signals86
Avg Return-2.42%
Long Upper Shadow
Score1/10
Win Rate40.74%
Hist. Signals81
Avg Return-3.33%
Score1/10
Win Rate40.74%
Hist. Signals81
Avg Return-3.33%
What is the current technical signals for DRMA?
- DRMA presents a Underperform setup with a Technical Score of 1.00/10. Key technical indicators highlight an RSI of 47.45 and a MACD of 0.02, with the trend anchored by the 50-Day SMA at 1.54. Traders should monitor key support at 1.15 and resistance at 1.25.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
